Childrens Ibuprofen Suspension
NDC Package 81033-019-01
Package Information
Childrens Ibuprofen (ibuprofen) suspension is ibuprofen is used to help relieve mild to moderate pain. This formulation utilizes a suspension delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-019 and is authorized under FDA application ANDA074937.
Identification & Billing
- RxCUI: 197803 - ibuprofen 100 MG in 5 mL Oral Suspension
- RxCUI: 197803 - ibuprofen 20 MG/ML Oral Suspension
- RxCUI: 197803 - ibuprofen 100 MG per 5 ML Oral Suspension
- RxCUI: 197803 - ibuprofen 200 MG per 10 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma Corporation
- 81033-019 - Childrens Ibuprofen
- 81033-019-01 - 100 CUP, UNIT-DOSE in 1 CASE / 5 mL in 1 CUP, UNIT-DOSE (81033-019-05)
- 81033-019 - Childrens Ibuprofen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (81033-019). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-019-01 identifies a specific commercial package of 100 cup, unit-dose in 1 case / 5 ml in 1 cup, unit-dose (81033-019-05) of Childrens Ibuprofen, a human over the counter drug labeled by Kesin Pharma Corporation. This suspension is formulated for oral use and contains ibuprofen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on April 28, 2011. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Ibuprofen is used to help relieve mild to moderate pain. When used with an opioid (such as morphine), it may be used to relieve moderate to severe pain. It is also used to reduce fever. Ibuprofen is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.
How is this Kesin Pharma Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033001901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.